Press "Enter" to skip to content

Fast-Acting Psychedelic Related With Enhancements In Anxiety

Researchers at Johns Hopkins have found that employment of the synthetic psychedelic 5-MeO-DMT (5-methocy-N,-N-dimethyltryptamine) seems to be related with unintended enhancements in self-reported anxiety and depression when given in a ritual group setting. 5-MeO-DMT is a psychedelic that is seen in a series of plants species, in the Bufo Alvarius toads’ venom, and can be created synthetically.

In a study of 362 people, almost 80% of respondents reported enhancements in depression and anxiety after employment. These enhancements were associated to stronger acute mystical impacts at the time of 5-MeO-DMT experience, as well as elevations in rating of the spiritual significance and personal meaning of the experience. Enhancements were also associated to more intense beliefs that the experience added to enduring life satisfaction and well-being. These outcomes were posted in The American Journal of Drug and Alcohol Abuse. One of the unique characteristics of 5-MeO-DMT is the short duration and fast action of the psychedelic effects when evaluated against other psychedelics.

On a related note, a new study can assist explain why stress in early life can generate anxiety disorders and vulnerabilities to mood later on. The research, spearheaded by scientists at The Ohio State University, was shown this week at the yearly Society for Neuroscience meeting in San Diego, and underlines the significant role of mast cells.

“These are immune cells comprised in allergic reactions that traditionally were overlooked by neuroscientists, but now we are discovering results in rodent models that they can be accountable for some of the modifications we witness after a childhood trauma in neurodevelopment,” claimed an assistant professor at Ohio State for psychology and the senior author of the study, Kathryn Lenz, to the media in an interview.

Angela Saulsbery (study lead author) claimed that she is especially interested in how this study may start to attract molecular-level links between adolescent & adult anxiety & depression and adverse childhood experiences.